Skip to main content

Site notifications

MESTINON pyridostigmine bromide 60mg tablets (New Zealand)

Section 19A approved medicine
MESTINON pyridostigmine bromide 60mg tablets (New Zealand)
Section 19A approval holder
iNova Pharmaceuticals (Australia) Pty Ltd ABN 13 617 871 539
Phone
1800 630 056
Approved until
Status
Current
Medicines in short supply/unavailable
MESTINON pyridostigmine bromide 60mg tablet bottle - ARTG 13748
Indication(s)

Useful in the treatment of myasthenia gravis.

Images
Picture of MESTINON pyridostigmine bromide 60mg tablets (New Zealand)

Help us improve the Therapeutic Goods Administration site